Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Verizon Communications Inc (VZ) Price & Performance

Enveric Biosciences IncTrade
Verizon Communications IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Verizon Communications Inc — how do they compare? Enveric Biosciences Inc trades at $1.58 (market cap $6.20M), while Verizon Communications Inc trades at $46.69 (market cap $196.40B). The key difference: Verizon Communications Inc is far larger — about 31677.4× Enveric Biosciences Inc's market cap, and Verizon Communications Inc pays a 5.99% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBVZ
Market Cap
$6.20M$196.40B
Sector
HealthMedia
52-Week High
$17.40$51.38
52-Week Low
$1.27$38.40
Enterprise Value
$1.30M$383.10B
Volume
22,584,735
Dividend Yield
5.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.

Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.

Verizon Communications Inc

Verizon (VZ) trades at $46.77, down 0.56% today, with a bullish technical signal from moving averages and a consensus analyst price target of $49.69. The company reported Q2 2026 EPS of $1.30, beating estimates, and maintains strong cash flow with $37.14B from operations in 2025. Recent news highlights partnerships, such as with Fi for pet tech integration, and network initiatives amid competitive pressures from SpaceX's Starlink.

Outlook: VZ offers value with a P/E of 12.31 and a 15.63% ROE, supported by stable dividends. Risks include rising debt to $298.5B in 2025 and revenue stagnation. Opportunities lie in fiber expansion and margin improvements, but investor caution is warranted due to competitive threats and macroeconomic uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Verizon Communications Inc

Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.

Read more on VZ